Submission Under Regulation 40(10) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Enclosed the Certificate in compliance with Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 received from a Practicing Company Secretary for the period from March 1, 2017 to September 30, 2017 Statement Of Investor Complaints For The Quarter Ended September 30, 2017
Enclosed copy of Statement on Investor Complaints under Regulation 13 (3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, for the Quarter ended 30th September, 2017 Compliance Certificate For The Period Ended September 30, 2017
Enclosed is the copy of Compliance Certificate to be filed under Regulation 7 (3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, for the half year ended September 30, 2017 Clarification
With reference to increase in Volume, Neuland Laboratories Ltd has submitted to BSE a copy of Clarification is enclosed. Clarification sought from Neuland Laboratories Ltd
The Exchange has sought clarification from Neuland Laboratories Ltd on October 5, 2017, with reference to increase in Volume.The reply is awaited. Shareholding for the Period Ended September 30, 2017
Neuland Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2017. For more details, kindly Click here Press Release / Media Release
Enclosing herewith the copies of newspaper publication on September 23, 2017 in respect of notice regarding Issue of duplicate share certificate. Press Release / Media Release
Attached herewith copies of the newspaper publication of Un-audited financial results for the quarter ended June 30, 2017, published in Financial Express and Andhra Prabha on September 12, 2017 for your reference Press Release / Media Release
A copy of the Press Release being issued by the Company on the Unaudited Financial Results for the quarter ended June 30, 2017. The same is being uploaded on the website of the Company. Financial Results For 30/06/2017
The Board of Directors, at its meeting held on even date, had approved the Unaudited Financial Results for the quarter ended June 30, 2017 and the limited review thereon by the auditors. The said financial results and limited review report by the auditors for the quarter ended June 30, 2017, are attached herewith.